Certolizumab (Cimzia)

Cimzia (certolizumab) is a biologic medicine that helps the pain and swelling of arthritis. It works by blocking Tumor Necrosis Factor (TNF), a type of signalling protein (called a cytokine), that is involved in systemic inflammation.

Cimzia belongs to a class of similar medications called “Anti-Tumor Necrosis Factor” agents.

Cimzia is used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Psoriasis, and Crohn’s Disease.

Taking Cimzia

Cimzia is available in pre-filled syringes or an autoinjectors and is usually taken once every 2 weeks.

Although some patients can feel better quite quickly in others it can take a little longer. Patients starting Cimizia should continue taking the medication as prescribed.

Important Tests and Risks




Watch Dr. Andy Thompson, a Canadian rheumatologist, introduce Cimzia in a short video:


Cimzia Quick Reference Guide


  • 02331675 (Pre-filled Syringe)
  • 02465574 (Autoinjector)